872611-92-2Relevant articles and documents
Development of albumin-binding doxorubicin pro-drugs that are cleaved by prostate-specific antigen
Kratz, Felix,Mansour, Ahmed,Soltau, Jens,Warnecke, Andre,Fichtner, Iduna,Unger, Clemens,Drevs, Joachim
, p. 462 - 472 (2005)
Prostate-specific antigen (PSA) is a serine protease that is overexpressed in prostate carcinoma and represents a molecular target for selectively releasing an anticancer agent from a prodrug formulation. In this work, we developed albumin-binding prodrug